KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palvella Therapeutics (PVLA) Return on Capital Employed (2016 - 2026)

Palvella Therapeutics has reported Return on Capital Employed over the past 9 years, most recently at 58.67% for Q3 2022.

  • Quarterly Return on Capital Employed fell 1023.0% to 58.67% in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 58.67% through Sep 2022, down 1023.0% year-over-year, with the annual reading at 65.84% for FY2021, 3222.0% down from the prior year.
  • Return on Capital Employed was 58.67% for Q3 2022 at Palvella Therapeutics, down from 55.23% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 7.87% in Q2 2018 and troughed at 58.67% in Q3 2022.
  • The 5-year median for Return on Capital Employed is 38.45% (2020), against an average of 35.37%.
  • Year-over-year, Return on Capital Employed skyrocketed 5369bps in 2018 and then plummeted -4030bps in 2019.
  • A 5-year view of Return on Capital Employed shows it stood at 31.32% in 2018, then rose by 15bps to 26.65% in 2019, then crashed by -44bps to 38.45% in 2020, then dropped by -24bps to 47.85% in 2021, then decreased by -23bps to 58.67% in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Return on Capital Employed are 58.67% (Q3 2022), 55.23% (Q2 2022), and 51.23% (Q1 2022).